SyntheMed Announces FDA Clearance Of SinusShield(TM)
Nov 21st 2008Drug InformationEar, Nose and Throat
SyntheMed, Inc. (OTC Bulletin Board: SYMD) announced that it has received FDA 510(k) clearance to market SinusShield(TM), a bioresorbable membrane intended to prevent post-operative adhesions in nasal and sinus surgical procedures. There are approximately two million nasal and sinus procedures performed annually in the United States. Robert P.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
